Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050683 · ClinicalTrials.gov registry record · NA
Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)
A NA study of Refractory Ascites, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04050683: Completed NA study of Refractory Ascites, sponsored by Medical College of Wisconsin.
NCT04050683 is a NA study of Refractory Ascites that has completed, run by Medical College of Wisconsin. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04050683, a NA study of Refractory Ascites, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
During a TIPS procedure, a shunt or stent (mesh tube) is passed down the jugular vein (the vein above the collarbone in the neck) using fluoroscopy (real time x-rays) guidance. Then, a stent is inserted between the portal vein (vein that carries blood from the intestines into the liver) to a hepatic vein (vein that carries blood away from the liver back to the heart). This means that blood that would usually gets filtered through the liver is now bypassing the liver and going directly to the heart. Because more blood will be flowing to the heart, the heart needs to be strong enough to handle the extra volume. This study is being done to determine the impact of the TIPS procedure on cardiac (heart) function by collecting data (heart pressures) during the TIPS procedure. Immediately after TIPS and at standard follow-up time points, labs and transthoracic echocardiograms (TTE or echo) will also be collected. The device(s) used in this study are neither the intervention studied nor the experimental variable of interest. Devices are commercially available and used, and procedures are performed, in accordance with the institution's standard of care.
Primary Outcome
any cardiac event to include, heart failure, heart attack, pulmonary hypertension
Conditions Studied
Interventions
- PROCEDURE Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- PROCEDURE Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Study Locations (1)
Wisconsin
- Medical College of Wisconsin/Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2024-12-09 |
| Phase | NA |
What the finished NCT04050683 record still lists
NCT04050683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Refractory Ascites appearing as the primary indexed condition, and to 2 interventions - of which Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS) is the first listed.
NCT04050683 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04050683 about?
NCT04050683 is a clinical study titled "Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)". During a TIPS procedure, a shunt or stent (mesh tube) is passed down the jugular vein (the vein above the collarbone in the neck) using fluoroscopy (real time x-rays) guidance. Then, a stent is inserted between the portal vein (vein that carries blood from the intestines into the liver) to a hepatic...
What is the current status of trial NCT04050683?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-09-25. Estimated completion is 2024-12-09.
What conditions does trial NCT04050683 study?
This clinical trial studies the following conditions: Refractory Ascites.
What interventions are being tested in trial NCT04050683?
The interventions under investigation include: Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS) (PROCEDURE), Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS) (PROCEDURE).
Who is sponsoring clinical trial NCT04050683?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04050683 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04050683's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI